CYP3A5 Genotype is Associated with Diagnosis of Hypertension in Elderly Patients: Data from the DEBATE Study

ISSN： 1175-2203

Source： American Journal of PharmacoGenomics, Vol.5, Iss.3, 2005-01, pp. : 191-195

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prospective data from a 5-year cohort study show that CNS drugs may impair mobility in elderly patients.

Reactions Weekly, Vol. 1, Iss. 1280, 2009-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Effects of the CYP3A5 genotype on omeprazole sulfoxidation in CYP2C19 PMs

By Sugimoto Katsuyoshi

European Journal of Clinical Pharmacology, Vol. 64, Iss. 6, 2008-06 ,pp. : 583-587

Springer Publishing Company

Access to resources Recommend Favorite

Olmesartan Medoxomil in Elderly Patients with Essential or Isolated Systolic Hypertension: Efficacy and Safety Data from Clinical Trials

By Heagerty Anthony M.

Drugs & Aging, Vol. 26, Iss. 1, 2009-01 ,pp. : 61-76

Adis International

Access to resources Recommend Favorite

Impact of CYP3A5 genotype on tacrolimus versus midazolam clearance in renal transplant recipients: new insights in CYP3A5-mediated drug metabolism

By de Jonge Hylke de Loor Henriette Verbeke Krisitin Vanrenterghem Yves Kuypers Dirk RJ

Pharmacogenomics, Vol. 14, Iss. 12, 2013-09 ,pp. : 1467-1480

Future Medicine

Access to resources Recommend Favorite

Challenges in CYP2D6 Phenotype Assignment from Genotype Data: A Critical Assessment and Call for Standardization

Current Drug Metabolism, Vol. 15, Iss. 2, 2014-02 ,pp. : 218-232

Bentham Science Publishers

Access to resources Recommend Favorite